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a  b  s  t  r  a  c  t
Rapid  and  accurate  diagnosis  is  essential  for  effective  control  of foot-and-mouth  disease  (FMD).  In
countries  where  FMD  is endemic,  identiﬁcation  of  the serotypes  of  the  causative  virus  strains  is  important
for  vaccine  selection  and  tracing  the  source  of outbreaks.  In this  study,  real-time  reverse  transcription
polymerase  chain  reaction  (rRT-PCR)  assays  using  primer/probe  sets  designed  from  the  VP1  coding  region
of the  virus  genomes  were  developed  for the  speciﬁc  detection  of  serotype  O,  A and Asia-1  FMD viruses
(FMDVs)  circulating  in  the  Middle  East.  These  assays  were  evaluated  using  representative  ﬁeld  samples
of serotype  O  strains  belonging  exclusively  to  the  PanAsia-2  lineage,  serotype  A strains  of the  Iran-05  lin-
eage  and serotype  Asia-1  viruses  from  three  relevant  sub-groups.  When  RNA  extracted  from  archival  and
contemporary  ﬁeld  strains  was  tested  using  one-  or two-step  rRT-PCR  assays,  all three  primer/probe  sets
detected  the  RNA  from  homotypic  viruses  and  no  cross-reactivity  was  observed  with  heterotypic  viruses.
Similar results  were  obtained  using  both  single-  and  multiplex  assay  formats.  Using plasmid  standards,
the  minimum  detection  level  of  these  tests  was  found  to be lower  than  two  copies.  The  results  illustrate
the  potential  of  tailored  rRT-PCR  tools  for the  detection  and  categorization  of  viruses  circulating  in  the
Middle  East  belonging  to  distinct  subgroups  of  serotypes  O,  A  and  Asia-1.  These  assays  can  also  overcome
the  problem  of  serotyping  samples  which  are  found  positive  by  the generic  rRT-PCR  diagnostic  assays  but
negative  by  virus isolation  and antigen-detection  ELISA  which  would  otherwise  have  to  be serotyped  by
nucleotide  sequencing.  A similar  approach  could  be  used  to  develop  serotyping  assays  for  FMDV  strains
circulating  in  other  regions  of  the  world.
© 2014  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Foot-and-mouth disease (FMD) is a highly contagious vesicular
disease of wild and domestic cloven-hoofed animals, particularly
cattle, sheep, pigs and goats. It is the most economically impor-
tant viral disease of domesticated livestock throughout the world
today, being endemic in many countries of Africa, Asia and South
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America. However, outbreaks can also occur in countries that are
normally free of FMD: including recently Japan and Korea (2000
and 2010), the United Kingdom (UK: 2001 and 2007), France and
The Netherlands (2001) plus Bulgaria (2010–2011). The causative
agent, FMD  virus (FMDV), is a single-stranded positive-sense RNA
virus of around 8.4 kilobases in length, belonging to the genus Aph-
thovirus within the family Picornaviridae (Belsham, 2005). There
are seven immunologically distinct serotypes: O, A, C, SAT (South-
ern African Territories) 1, SAT 2, SAT 3 and Asia-1 which encompass
a diverse antigenic spectrum of virus strains. The seven serotypes
are not distributed equally around the world (Knowles and Samuel,
2003). Serotypes O and A are widely disseminated but type C viruses
have not been detected since 2004, while Asia-1, despite having
been detected in Greece, is mainly conﬁned to the Asian continent.
http://dx.doi.org/10.1016/j.jviromet.2014.07.002
0166-0934/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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The SAT serotypes are normally, but not exclusively, restricted to
sub-Saharan Africa.
In countries normally free of FMD, rapid conﬁrmation of FMDV
as the causative agent in material from suspect disease cases is
the primary goal of ﬁeld and laboratory investigations. A number
of generic (pan-serotypic) real-time reverse transcription poly-
merase chain reaction (rRT-PCR) assays have been developed to
target highly conserved regions of the RNA genome of FMDV (Reid
et al., 2002; Callahan et al., 2002; Moniwa et al., 2007) which
efﬁciently detect all seven serotypes in clinical samples. These
assays have undergone extensive evaluation; parallel testing of
samples has shown that the sensitivity of these molecular assays
is at least equal to that of the current “gold standard” method
of virus isolation in cell culture (Shaw et al., 2004; Ferris et al.,
2006; King et al., 2006; Reid et al., 2009). However, a limitation of
the rRT-PCR procedures targeting conserved sequences in untrans-
lated regions of the genome or those encoding non-structural
proteins is that they cannot determine the serotype of the causative
FMDV. Therefore, using these assays it is not possible to identify
the serotype of virus samples that are positive by rRT-PCR but
virus isolation (VI)/antigen-detection ELISA (Ag-ELISA) negative.
Serotyping of these samples may  only be accomplished by the use of
serotype-speciﬁc primers and probes and/or nucleotide sequenc-
ing. Serotype-speciﬁc primer/probe sets may  also be speciﬁcally
beneﬁcial to those countries that currently use only the generic
rRT-PCR assays or a combination of generic rRT-PCR and Ag-ELISA
but not VI.
In FMD-endemic countries, identiﬁcation of the serotypes of
the causative virus strains is important for vaccine selection, dis-
ease containment and for tracing the source of the outbreaks.
Conventional RT-PCR procedures using primers corresponding to
the VP1 (1D) coding region and to the 2A/2B coding regions for
serotyping of FMDV have been reported (Vangrysperre and De
Clercq, 1996; Callens and De Clercq, 1997). However, subsequent
studies have shown that these agarose gel-based assays have
relatively poor sensitivity and speciﬁcity due to the genetic diver-
sity within all FMDV serotypes (Reid et al., 1999, 2001). While
these procedures can be used in conjunction with Ag-ELISA and
VI to provide additional information, they are insufﬁciently sen-
sitive to replace them for primary diagnosis of FMD  (Reid et al.,
1999). Alternative RT-PCR assays reported by Suryanarayana et al.
(1999) and Alexandersen et al. (2000) for serotype-speciﬁc diag-
nosis were cumbersome and unsuitable for routine use in the
event of an epidemic. A conventional RT-PCR procedure for dif-
ferentiation of FMDV serotypes native to India using multiple
primers based mostly on nucleotide sequences of viruses circulat-
ing in that geographical area was described by Giridharan et al.
(2005). These studies demonstrated the potential for using tai-
lored molecular tools to identify speciﬁc serotypes as an alternative
or addition to pan-serotypic assays for detection of FMDV. More
recently, the development and evaluation of a real-time reverse
transcription-loop-mediated isothermal ampliﬁcation assay for
rapid serotyping of FMDV has been reported (Madhanmohan et al.,
2013).
The objective of this study was to develop tailored rRT-PCR
methods for identiﬁcation of FMDV serotypes. In addition to
using these tools in endemic countries, such an approach would
overcome the problem of serotyping samples which are posi-
tive by pan-serotypic rRT-PCR but cannot be sequenced using
standard protocols. This collaborative study between the WRLFMD
(The Pirbrirhgt Institute, UK), Technical University of Denmark
(DTU) and Khorasan Razavi Central Veterinary Laboratory in
Iran (CVL) describes the development and evaluation of tailored
serotype-speciﬁc rRT-PCR assays for the detection of archival and
contemporary strains of FMDV serotypes O, A and Asia-1 circulating
in the Middle East.
2. Materials and methods
2.1. Virus isolates and sample preparation
FMDV isolates were selected from archival stocks held in the
WRLFMD (Pirbright Institute, UK) repository at −20 ◦C and con-
temporary submissions from within the serotype O PanAsia-2 and
serotype A Iran-05 lineages, respectively, serotype Asia-1 sub-
groups 1, 2 and 6, plus representative FMDV-Genome Detected
samples of undetermined serotype (FMDV-GD: Ag-ELISA and VI
negative). To check the diagnostic speciﬁcity of the serotype-
speciﬁc primer/probe sets, archival and currently circulating
serotype O and A viruses belonging to other topotypes (geo-
graphically and genetically distinct evolutionary lineages; Knowles
and Samuel, 2003) and serotype Asia-1 viruses from other sub-
groups were also tested. A further check on the speciﬁcity of the
primer/probe sets was made by testing FMDV strains belonging to
serotypes C, SAT 1 and SAT 2 plus representative strains of swine
vesicular disease virus (SVDV) which are capable of causing clini-
cally indistinguishable (‘look-alike’) disease to that caused by FMDV
in pigs and some samples, designated ‘NVD’, from which no virus
was detected by either Ag-ELISA, VI or pan-serotypic rRT-PCR. Most
samples comprised ∼10% (w/v) original suspensions of vesicular
epithelium (OS; Ferris and Dawson, 1988) which had been tested
by Ag-ELISA and VI (Ferris and Dawson, 1988) at the time of receipt.
Additional clinical samples such as saliva samples or homogenates
generated from heart tissue were also tested, and cell culture super-
natants of selected strains were tested when OS was unavailable. All
the samples tested are listed in the supplementary data—Annexes
A and B.
2.2. Total nucleic acid extraction
Total nucleic acid was extracted from the samples by an
automated procedure (Shaw et al., 2007). Prior to nucleic acid
extraction, 0.2 ml  of OS, saliva or cell culture-grown viruses were
added per 0.3 ml  of Lysis/Binding Buffer (Roche) or 0.2 ml  of OS or
cell culture-grown virus was  added to 1.0 ml  of TRIzol® Reagent
(Invitrogen) and stored at −70 ◦C. Nucleic acid extraction was also
performed manually using a QIAamp Viral RNA MiniKit (Qiagen)
according to the manufacturer’s instructions.
2.3. Primer and probe design
GenBank sequences (http://www.ncbi.nlm.nih.gov/) were
aligned from the VP1 coding region of the FMDV genome for
serotype O PanAsia-2, serotype A Iran-05 and Asia-1 strains of sub-
groups 1, 2 and 6, respectively, using BioEdit (http://www.mbio.
ncsu.edu/bioedit.html). Hydrolysis (TaqMan®) probes and primers
were designed from conserved sequences using PrimerExpress
version 3.0 software (Applied Biosystems).
In pilot experiments, for serotypes O and A, two  candidate for-
ward primers, two reverse primers and one probe were designed
for evaluation. Four forward primers, two  reverse primers and
four probes were evaluated in all combinations for detection of
Asia-1 virus sequences of the three targeted subgroups of this
serotype. The best-performing primer/probe sets for each serotype
were selected after all sets were tested by one-step rRT-PCR
using an ampliﬁcation protocol adapted for routine diagnosis of
FMDV (Shaw et al., 2007) with template nucleic acid extracted
from serotype O PanAsia-2, serotype A Iran-05 and Asia-1 viruses
(subgroups 1, 2 and 6, including the recently circulating Asia-
1/Sindh-08 lineage), respectively (data not shown). Table 1 lists
the sequences of the best-performing primer/probe sets.
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Table 1
FMDV serotype-speciﬁcity and sequence of the primers/probe sets.
Primer/probe name Orientation FMDV serotype speciﬁcity Sequence (5′–3′)
TypeOforprimer1 Forward Oa CCGAGACAGCGTTGGATAACA
TypeOrevprimer1 Reverse O CCATACTTGCAGTTCCCGTTGT
PanAsiaOprob349 Forward O FAM-CCGACTTGCACTGCCTTACACGGC-TAMRA
TypeAforprimer2 Forward Ab ACGACCATCCACGAGCTYC
TypeArevprimer2 Reverse A RCAGAGGCCTGGGACAGTAG
AIran05probe Forward A FAM-CGTGCGCATGAAACGTGCCG-TAMRA
Asia1forward3 Forward Asia-1c GCAGTWAAGGCYGAGASCATYAC
Asia1reverse2 Reverse Asia-1 GCARAGGCCTAGGGCAGTATG
Asia1probe4 Forward Asia-1 FAM-AGCTGTTGATCCGCATGAAACGYGCG-TAMRA
a FMDV serotype O PanAsia-2 lineage.
b FMDV serotype A Iran-05 lineage.
c FMDV serotype Asia-1 subgroups 1, 2 and 6.
2.4. Evaluation of the FMDV serotype-speciﬁc primer/probe sets
in assays on clinical samples
Clinical samples were tested at the WRLFMD (Pirbright
Institute, UK) by one-step rRT-PCR assays using the serotype-
speciﬁc primer/probe sets run in parallel with the generic FMDV
primer/probe sets targeting the 5′ UTR (Reid et al., 2002) and 3D
coding region (Callahan et al., 2002) using the protocol of Shaw
et al. (2007). The pan-serotypic assays, targeting independently
conserved regions of the FMDV genome, also served to determine
the presence of FMDV RNA. All rRT-PCR reactions were set-up
manually and ampliﬁcations performed in a Stratagene Mx3005P
thermal cycler.
At DTU (Lindholm, Denmark), two-step rRT-PCR assays were
performed with random primers for cDNA preparation followed
by rRT-PCR ampliﬁcation targeting the 5′ UTR (Reid et al., 2002),
3D coding region (Callahan et al., 2002) or using the serotype-
speciﬁc primer/probe sets. Fifty cycles of replication were used in
a Stratagene Mx3005P thermal cycler.
The CVL (Iran) methodology used both one- and two-step rRT-
PCR protocols with the best-performing serotype O, A and Asia
primers/probe sets from Table 1. Ampliﬁcation by rRT-PCR was
performed in a Lightcycler 480 (Roche) or ABI 7500 (Applied
Biosystems) thermal cyclers with the following ampliﬁcation pro-
gramme: an RT step of 50 ◦C for 30 min; denaturation at 95 ◦C for
15 min, 1 cycle; 94 ◦C for 30 s, 60 ◦C for 1 min, 50 cycles.
2.5. Evaluation of FMDV serotype-speciﬁc primer/probe sets in
multiplex assays
The individual serotype-speciﬁc assays were combined together
in a multiplex format that allowed single RNA samples to be simul-
taneously tested for all three targets within the same tube. The
reactions were set up as a multiplex assay with the probe targeting
FMDV serotype O labelled with 5′-Cy5 and 3′-Black Hole Quencher
(BHQ) 2, the probe targeting FMDV serotype A labelled with 5′-
FAM and 3′-BHQ1 and the probe targeting FMDV serotype Asia-1
labelled with 5′-Cy3 and 3′-BHQ2 (Sigma-Aldrich, UK). Cycling con-
ditions used in these assays were identical to those used for the
individual assays. The diagnostic performance of the multiplex
assay was compared to the individual component (singleplex) rRT-
PCR assays.
2.6. Preparation of RT-PCR products suitable as standards for the
serotype-speciﬁc rRT-PCR assays
RT reactions (in 20 l) were set up containing 4 l of RNA
from O/IRN/8/2005, A/IRN/1/2005 and Asia 1/IRN/10/2004 using
SuperScriptTM III reagents (Invitrogen, Paisley, UK) according to the
manufacturer’s instructions with 10 M each of the reverse primers
(Table 2). Primers, RNA, water and dNTPs were ﬁrst combined and
the mixture heated to 65 ◦C for 5 min, followed by chilling on ice.
The remaining reagents were subsequently added and heated at
50 ◦C for 60 min  followed by a 15 min  inactivation step at 95 ◦C. PCRs
were prepared using a Platinum® Taq system (Invitrogen, Pais-
ley, UK) according to the manufacturer’s instructions with 10 M
each of the primers (Table 2). Ampliﬁcation resulted in the produc-
tion of fragments of 231, 168 and 197 bp for serotypes O, A and
Asia-1, respectively, corresponding to the assay target region. The
PCR cycling protocol (Bio-Rad Laboratories, Herts, UK) included 30
cycles consisting of 30 s each of denaturation at 94 ◦C, annealing
at 55 ◦C and extension at 68 ◦C. On completion of cycling, an addi-
tional extension step of 10 min  at 68 ◦C was carried out followed
by a ﬁnal hold step at 4 ◦C. Resultant PCR products were visualised
on 2% (w/v) agarose gels (Sigma-Aldrich, UK), before being excised
from the agarose gel and puriﬁed using a Qiaquick Gel Extraction Kit
(Qiagen, Crawley, UK) according to the manufacturer’s instructions.
2.7. Preparation of plasmid standards for determination of
analytical sensitivity of serotype-speciﬁc rRT-PCR assays
The ampliﬁed assay target regions were cloned into a pGEMT
Easy vector (Promega, UK) according to the manufacturer’s instruc-
tions. A number of positive colonies were grown overnight in 3 ml of
LB-broth containing 50 g/ml of ampicillin. Plasmids were puriﬁed
using a Qiagen plasmid mini kit (Qiagen, Crawley, UK) according
to the manufacturer’s instructions and tested for the presence of
the assay target region by PCR with the same primers. The correct
sequence and orientation was conﬁrmed by sequencing with M13
forward and reverse primers (Promega, UK) on a 3730 DNA anal-
yser (Applied Biosystems, Warrington, UK) by dideoxy-sequencing
Table 2
FMDV serotype speciﬁcity, sequence and amplicon size with the primer sets used to make standards.
Primer name Sequence (5′–3′) FMDV serotype speciﬁcity Size (bp)
SeroOquantfor TCG CAG ACC TCG AGG TGG O (IRN 8/2005) 231
SeroOquantrev CTT GCA GGT CAC CTC TCA CG O (IRN 8/2005)
PEXSeroAquantfor GGG GTG ACC TGG GGC CTC TTG CG A (IRN 1/2005) 168
PEXSeroAquantrev TGT CCT GCG ACA ACA CTT CCA C A (IRN 1/2005)
PEXSeroAsia1quantfor GGA AAC AAC CTC ACG GCG TGG TG Asia 1 (IRN 10/2004) 197
PEXSeroAsia1quantrev TCT CCT GTT TAC GGC GAT CCT G Asia 1 (IRN 10/2004)
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using a Big Dye® Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems) following the manufacturer’s instructions.
RNA was transcribed from 0.4 g of linearised pGEMT plasmids
from the T7 promoter site using a MEGAscript® T7 in vitro transcrip-
tion kit (Ambion, Warrington, UK) according to the manufacturer’s
instructions except that transcription was continued overnight.
Transcribed RNA was quantiﬁed using a Nanodrop (Thermo Scien-
tiﬁc, UK) and veriﬁed by running 1 l RNA on a BioAnalyser (Agilent,
UK) using the RNA 6000 Nano kit (Agilent, UK).
2.8. Determination of the dynamic range and analytical
sensitivity of the serotype-speciﬁc assays using the RNA and
plasmid standards
Dilutions of the RNA transcripts containing between 1012 and
100 copies/l  were used as target material to test the dynamic
range and sensitivity of the single- and multiplex assays. Real-time
RT-PCR was carried out using Superscript III Platinum® One-Step
qRT-PCR reaction mix  and 0.5 l enzyme (Invitrogen, Paisley, UK).
The ﬁnal reaction volume (25 l) included 1.5 l of probe at
5 pmol/l; 2 l of each primer at 10 pmol/l,  12.5 l 2× reaction
mix, 1.5 l of DEPC-water (Ambion, Warrington, UK) per reac-
tion and 5 l of target RNA. Real-time RT-PCR reactions, including
standard RNA material of between 1012 and 100 copies/l, were
carried out in quadruplicate in an Mx3005p real-time thermal
cycler (Stratagene, UK). For these experiments, the thermal cycling
conditions included a single 60 ◦C cDNA synthesis step for 30 min
followed by a 95 ◦C denaturation step of 10 min  before PCR cycling
which included 50 cycles consisting of 15 s each of denaturation
at 95 ◦C, and annealing/extension at 60 ◦C for 1 min  (as previously
described; Shaw et al., 2007).
3. Results
3.1. Diagnostic sensitivity and speciﬁcity of serotype-speciﬁc
rRT-PCR primer/probe assays in singleplex and multiplex assay
formats
3.1.1. Singleplex rRT-PCR assay format
RNA samples derived from known or suspect cases of FMD
were assayed initially in singleplex rRT-PCR assays. Threshold
cycle (CT) values were assigned to each reaction as previously
described (Reid et al., 2002). As for routine diagnosis using the pan-
serotypic one-step rRT-PCR assays, a CT value of 32.0 was used as
the positive/negative cut-off point (Shaw et al., 2007; Reid et al.,
2009). A deﬁnitive positive/negative cut-off was not assigned to
the serotype-speciﬁc rRT-PCR assays; the strongest result (i.e. low-
est CT value) generated for each sample from either the serotype O,
A or Asia-1-speciﬁc primer/probe set was used to designate an O,
A or Asia-1 serotype for that sample.
Singleplex assay data generated from WRLFMD, DTU and CVL
are summarised in Table 2 and the results from the individual
samples are listed in supplementary data—Annex A. Assays with
the pan-serotypic primers and probes conﬁrmed the presence of
FMDV RNA within each sample. As expected, both pan-serotypic
assays (targeting the 5′ UTR and 3D coding regions) demon-
strated a broader spectrum of reactivity than the serotype-speciﬁc
primer/probe sets and detected the genomes of serotype C, SAT
1 and SAT 2 viruses, as well as being broadly reactive against
serotype O, A and Asia-1 viruses across all topotypes/lineages. All
three serotype-speciﬁc primer/probe sets tested were strongly pos-
itive using RNA extracted from homotypic serotype O, A and Asia-1
viruses of the targeted lineage or subgroup. There were only three
instances, all involving the serotype O-speciﬁc primers/probe set,
when homotypic viruses of the non-targeted lineage, were detected
(viruses belonging to the topotypes EA-3, EA-4 and CATHAY).
The speciﬁc primer/probe sets were successful in identifying
four of the 12 FMDV-GD samples tested as serotype O and seven of
these samples were serotype A. Of the 12 FMDV-GD samples tested
by the singleplex format, 9 and 10 samples, respectively, were pos-
itive by the 5′ UTR and 3D pan-serotypic PCR assays, however, two
samples testing positive using the serotype A-speciﬁc primer/probe
set were negative in assays with pan-serotypic primer/probe sets.
No cross-reactivity was observed when the speciﬁc
primer/probe sets were tested with heterotypic type O, A or
Asia-1 isolates except when testing the serotype O PanAsia-2
sample O/PAK/4/2006 which also produced a weak reaction (of
higher CT value) against the serotype A-speciﬁc primers/probe
set. This sample may  have been a dual serotype O/A infection but
as a stronger CT value (28.33) was produced with the serotype
O primer/probe set than that resulting from the heterologous
serotype A set (CT value of 31.55), a serotype O identiﬁcation
could be correctly deduced for this sample. Furthermore, no
cross-reactivity was  observed when all three serotype-speciﬁc
primer/probe sets were tested against the heterologous FMDV
serotypes C, SAT 1 and SAT 2 or with SVDV isolates (Table 3).
A two-step singleplex rRT-PCR format was  also used at DTU and
at CVL in parallel with the one-step format (data summarised in
Table 3). Like the one-step approach, the two-step assays with the
speciﬁc primer/probe sets were strongly reactive with the target-
ted type O strains of PanAsia-2 lineage, type A strains of the Iran-05
lineage and Asia-1 viruses from subgroups 1 and 2, respectively,
but overall assay performance was  better with the one-step for-
mat  (data not shown). No cross-reactivity was observed when the
serotype-speciﬁc primer/probe sets were tested using the two-step
format assays against the heterologous serotype C, SAT 1, SAT 2 and
SAT 3 FMDVs.
3.1.2. Multiplex rRT-PCR assay format
The positive/negative acceptance criteria adopted for the pan-
serotypic and serotype-speciﬁc rRT-PCR assays using the singleplex
format were similarly applied for the multiplex assays performed
at the WRLFMD. Multiplex assay data are summarised in Table 3
and the CT values from individual samples are listed in supple-
mentary data—Annex B. Speciﬁcity of detection using the serotype
O, A and Asia-1 primer/probe sets is also apparent from the heat
maps (Fig. 1a–c, respectively). These clearly demonstrate the strong
speciﬁcity of recognition of the primer/probe sets against the tar-
getted virus sequences of the isolates belonging to the serotype
O PanAsia-2 lineage (Fig. 1a), serotype A Iran-05 lineage (Fig. 1b)
and Asia-1 subgroups 1 and 2 (Fig. 1c), respectively. However, one
sample (O/BAR/1/2008) did not generate a positive results for the
multiplex assay although the singleplex version of this test gave a
positive signal.
The samples Asia-1/PAK/32/2011 and Asia-1/PAK/109/2011
were among ﬁve Asia-1 viruses in the Asia-1/Sindh-08 lineage not
detected by the Asia-1-speciﬁc primers/probe sets. Both viruses
had two  mismatches in the probe-binding region resulting in false-
negative rRT-PCR results. Table 4 shows the sequences of selected
Asia-1 viruses, highlighting mismatches in the primer and probe
regions. All other Asia-1 viruses listed in Table 4 were detected by
the multiplex assay.
The multiplex assay format was also successful in assigning the
serotypic identity to samples designated as FMDV-GD (Table 3,
supplementary data—Annex B and heat map; Fig. 1d). Eighty-ﬁve
FMDV-GD samples were tested (77 and 82 had tested positive by
the 5′ UTR and 3D assays, respectively) and of these, serotype
O identity was assigned to 33 samples, 17 were designated as
serotype A and four samples were designated as serotype Asia-1.
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Table 3
Summary of the rRT-PCR results using serotype O-, A- and Asia-1-speciﬁc and pan-serotypic 5′ UTR and 3D primers/probe sets in multiplex and singleplex assay formats.
FMDV serotype
or other
vesicular virus
FMDV
topotypea
FMDV
lineageb
Ratio of number of samples positive to total
number tested by rRT-PCRc
Ratio of number of samples positive to total
number tested by rRT-PCRc
Multiplex assay formatd Singleplex assay formate,f
Og Ah Asia-1i 5′UTR 3D Og Ah Asia-1i 5′UTR 3D
O ME-SA PanAsia-2 12/13 0/13 0/13 13/13 13/13 26/26e 5/5f 1/26e 0/5f 0/26e 0.5f 23/26e 5/5f 24/26e 5/5f
ME-SA PanAsia-2ANT-10 19/19 0/19 0/19 18/19 19/19 17/18e 0/18f 0/18f NTj 18/18f
ME-SA PanAsia-2FAR-09 2/2 0/2 0/2 2/2 2/2 NT NT NT NT NT
ME-SA PanAsia 5/5 0/5 0/5 5/5 5/5 NT NT NT NT NT
ME-SA Unnamed 1/1 0/1 0/1 1/1 1/1 NT NT NT NT NT
ME-SA Ind-2001d 1/1 0/1 0/1 1/1 1/1 NT NT NT NT NT
SEA  Unnamed 0/2 0/2 0/2 2/2 2/2 0/1e 0/1e 0/1e 1/1e 1/1e
SEA Mya-98 1/10 0/10 0/10 10/10 10/10 NT NT NT NT NT
EA-1  Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e
EA-2 Unnamed 0/2 0/2 0/2 2/2 2/2 0/2e 0/2e 0/2e 2/2e 2/2e
EA-3 Unnamed 0/1 0/1 0/1 1/1 1/1 1/2e 0/2e 0/2e 2/2e 2/2e
EA-4 Unnamed 0/1 0/1 0/1 1/1 1/1 1/1e 0/1e 0/1e 1/1e 1/1e
WA Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e
ISA-1 Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e
ISA-2 Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e
CATHAY Unnamed 0/3 0/3 0/3 3/3 3/3 1/2e 0/2e 0/2e 2/2e 2/2e
A ASIA Iran-05AFG-07 0/16 16/16 0/16 15/16 16/16 NT NT NT NT NT
ASIA  Iran-05FAR-09 0/1 1/1 0/1 1/1 1/1 NT NT NT NT NT
ASIA  Iran-05BAR-08 0/4 4/4 0/4 4/4 4/4 NT NT NT NT NT
ASIA  Iran-05 0/17 17/17 0/17 17/17 17/17 0/22e 0/9f 22/22e 8/9f 0/22e 0/9f 22/22e 5/9f 22/22e 8/9f
ASIA Iran-05EZM-07 0/1 1/1 0/1 1/1 1/1 NT NT NT NT NT
ASIA  Iran-05QAZ-11 0/2 2/2 0/2 2/2 2/2 NT NT NT NT NT
ASIA  Iran-05ESF-10 0/1 1/1 0/1 1/1 1/1 NT NT NT NT NT
ASIA  Iran-87 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e
ASIA Iran-96 NT NT NT NT NT 0/3e 0/2f 0/3e 0/2f 0/3e 0/2f 2/3e 2/2f 3/3e 2/2f
ASIA Sea-97 0/4 2/4 0/4 4/4 4/4 NT NT NT NT NT
AFRICA G-VIII 0/2 1/2 0/2 2/2 2/2 0/2e 1/2e 0/2e 2/2e 2/2e
EURO-SA A24 0/1 1/1 0/1 1/1 1/1 0/1e 1/1e 0/1e 1/1e 1/1e
EURO-SA A12 0/1 1/1 0/1 1/1 1/1 0/1e 1/1e 0/1e 1/1e 1/1e
AFRICA G-VII 0/2 1/2 0/2 2/2 2/2 0/2e 1/2e 0/2e 2/2e 2/2e
AFRICA G-II 0/1 0/1 0/1 1/1 1/1 1/1e 0/1e 0/1e 1/1e 1/1e
AFRICA G-VI 0/2 0/2 0/2 2/2 2/2 0/2e 0/2e 0/2e 2/2e 2/2e
AFRICA G-V 0/1 1/1 0/1 1/1 1/1 0/1e 1/1e 0/1e 1/1e 1/1e
AFRICA G-IV 0/1 0/1 0/1 1/1 1/1 NT NT NT NT NT
Asia-1  ASIA Unnamed 0/4 0/4 4/4 4/4 4/4 0/1e 0/1e 0/1e 1/1e 1/1e
ASIA Sindh-08 0/12 0/12 7/12 12/12 12/12 NT NT NT NT NT
ASIA  Group 1 NT NT NT NT NT 0/4e 0/1f 0/4e 0/1f 4/4e 1/1f 4/4e 1/1f 4/4e 1/1f
ASIA Group 2 0/2 0/2 2/2 2/2 2/2 0/6e 0/6f 0/6e 0/6f 6/6e 6/6f 6/6e 1/2f 6/6e 6/6f
ASIA Group 4 NT NT NT NT NT 0/1e 0/1e 1/1e 1/1e 1/1e
ASIA Group 5 NT NT NT NT NT 0/1e 0/1e 1/1e 1/1e 1/1e
ASIA Group 6 NT NT NT NT NT 0/2e 0/2e 2/2e 2/2e 2/2e
C NT NT NT NT NT 0/1e 0/1f 0/1e 0/1f 0/1e 0/1f 1/1e 1/1f 1/1e 1/1f
SAT 1 0/3 0/3 0/3 2/3 3/3 0/4e 0/1f 0/4e 0/1f 0/4e 0/1f 2/4e 1/1f 4/4e 1/1f
SAT 2 0/3 0/3 0/3 3/3 3/3 0/4e 0/4f 0/4e 0/4f 0/4e 0/4f 4/4e 1/1f 4/4e 4/4f
SAT 3 NT NT NT NT NT 0/1f 0/1f 0/1f 1/1f 1/1f
FMDV-GDk 33/85 17/85 4/85 77/85k 82/85k 4/12e 7/12e,m 0/12e 9/12e,m 10/12e,m
SVDV n 0/3 0/3 0/3 0/3 0/3 0/3e 0/3e 0/3e 0/3e 0/3e
NVDo 0/4 0/4 0/4 0/4 0/4 NT NT NT NT NT
a FMDV topotypes: ME-SA, Middle East-South Asia; SEA, South East Asia; EA-1, EA-2, EA-3 and EA-4, East Africa 1–4; WA,  West Africa; ISA1, ISA-2, Indonesia 1 and 2.
b http://www.wrlfmd.org/fmd genotyping/prototypes.htm.
c For pan-serotypic rRT-PCR assays, samples producing a CT value <32.0 were considered positive; with all serotype-speciﬁc rRT-PCR assays, the lowest CT value generated
amongst the primers/probe sets used deﬁned the serotype. Results in bold type represent apparent anomalous results where positive results were achieved by the speciﬁc
primer/probe set using RNA extracted from homotypic serotype O, A and Asia-1 viruses homotypic viruses of the non-targeted lineage lineage or subgroup.
d All multiplex data were generated at the WRLFMD.
e Singleplex data generated at the WRLFMD using one-step rRT-PCR assays.
f Singleplex data generated from DTU and CVL using either one- or two-step rRT-PCR assays.
g Primers/probe set: TypeOforprimer1/TypeOrevprimer1/PanAsiaOprob349.
h Primers/probe set: TypeAforprimer2/TypeArevprimer2/AIran05probe.
i Primers/probe set: Asia1forward3/Asia1reverse2/Asia1probe4.
j NT, not tested.
k FMDV-GD, FMDV-genome detected samples, i.e. samples of undetermined serotype that are positive by rRT-PCR but VI/Ag-ELISA-negative.
l Thirty-six samples were FMDV-genome detected (by at least one generic primers/probe set) but negative using serotype-speciﬁc primers/probe sets.
m Two samples were positive using TypeAforprimer2/TypeArevprimer2/AIran05probe set were negative using pan-serotypic primer/probe sets.
n SVDV, swine vesicular disease virus.
o NVD, no virus detected in the sample.
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Fig. 1. Diagnostic sensitivity and speciﬁcity of the lineage-speciﬁc rRT-PCR assays in multiplexed format (together with comparative data for the pan-serotypic rRT-PCR
assays) to detect representative FMD  virus positive samples from serotype O PanAsia-2 lineage (a), serotype A Iran-05 lineage (b) and Asia-1 subgroups 1 and 2 (c). Data are
presented as a heat-map for CT values generated with the different rRT-PCR assays (scale shown). Neighbor-joining trees shown represent genetic relationships between
VP1  sequences for the individual viruses. Individual data values are presented in supplemental data.
Table 4
Sequences of serotype Asia-1 FMDV samples highlighting mismatches with primers and probe sequences. Samples Asia-1/PAK/32/2011 and Asia-
1/PAK/109/2011 were not detected by the multiplex rRT-PCR assay.
21
Asia-1 FMDV sample Forward primer  (5’  -3’) Pro be (5’ – 3’) Re verse primer 3’ -5’)
GCAGTWAAGGCYGAGASCATYAC AGCTGTTGATCCGCATGAAACGYGCG CATACTGCCCTAGGCCTYTGC
Asia-1/PAK/89/2011 ..............A.A...... .....C.................... ..........C..........
Asia-1/AFG /48/2011 ..............A.A...... .....C.................... ..........C..........
Asia-1/AFG /51/2011 ..............A.A...... .....C.................... ..........C..........
Asia-1/AFG /55/2011 ..............A.A...... .....C.................... ..........C..........
Asia-1/BAR/3/2011 ..............A.A...... ..T..C.................... .......T..C..........
Asia-1/BAR/4/2011 ..............A.A...... ..T..C.................... .......T..C..........
Asia-1/IRN/33/2011 ..............A.A...... ..T..C.................... ..........C..........
Asia-1/IRN/38/2011 ..............A.A...... ..T..C.................... ..........C..........
Asia-1/IRN/43/2011 ..............A.A...... ..T..C.................... ..........C..........
Asia-1/IRN/46/2011 ..............A.A...... ..T..C.................... ..........C..........
Asia-1/PAK/90/2011 ..............A.A...... ..T..C.................... ..........C..........
Asia-1/PAK/32/2011 ..............A.A...... .....C....A............... ..........C..........
Asia-1/PAK/109/2010 ..............A.A...... .....C....A............... ..........C..........
3.2. Analytical sensitivity/minimum detection level of
serotype-speciﬁc rRT-PCR primers/probe assays
Fig. 2a–c shows the wide dynamic range of the single-
plex assays using plasmid standards with the serotype O-, A-
and Asia-1-speciﬁc primer/probe sets. Using DNA templates,
the three assays had a limit of detection of 1.78, 2.58 and
2.74 copies, respectively, thus demonstrating the high ana-
lytical sensitivity of these tests. The ampliﬁcation efﬁciencies
for these three assays were estimated to be 94.9, 93.3 and
99.2%, for the serotype O, A and Asia-1 assays, respectively.
Of the two  formats, the singleplex assay format had a lower
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Fig. 2. Analytical sensitivity and demonstration of the dynamic range of the rRT-PCR assays using plasmid standards with the serotype O- (a), A- (b) and Asia-1- (c) speciﬁc
primer/probe sets.
minimum detection level than the multiplex version (data not
shown).
4. Discussion
While pan-serotypic rRT-PCR assays for detection of FMDV have
been extensively evaluated for routine use (Callahan et al., 2002;
Shaw et al., 2004; Moniwa et al., 2007), several challenges face the
design of serotype-speciﬁc primer/probe sets for rRT-PCR. In silico
analyses can be used to try to identify conserved sequences for
primer/probe binding sites that allow the speciﬁc recognition of all
viruses within a particular serotype, but do not cross-react with
viruses of other serotypes. This process is challenging due to the
high variability of the FMDV genome and lack of sequences that
are conserved within, but restricted to, a particular serotype. For
these reasons, efforts here have concentrated on detecting viruses
of particular serotypes from within distinct geographical regions
or lineages rather than across all strains globally within a serotype.
This current study utilised VP1 coding sequences to design and
establish serotype-speciﬁc rRT-PCR assays; VP1 is one of the capsid
proteins which displays epitope(s) on the virus surface to the host’s
immune system. VP1 is widely accepted as being the most anti-
genically signiﬁcant of the capsid proteins and its sequence can be
used to identify the serotype of the strain. The VP1 coding sequence
has been the most commonly sequenced and hence it is now the
most informative region of the FMDV genome for determining the
relationship between different strains for epidemiological analyses.
Initial screening of clinical samples in three different lab-
oratories using singleplex assay formats showed that the
serotype-speciﬁc primer/probes sets appropriately detected the
FMDV genome of serotype O PanAsia-2, serotype A Iran-05 and
Asia-1 strains of subgroups 1, 2 and 6 as intended (Table 3 and sup-
plementary data—Annex A). Furthermore, the assays discriminated
between viruses belonging to these lineages from viruses of other
lineages or subgroups within serotypes O, A and Asia 1, e.g. from
other regions of the world. No cross-reactivity was demonstrated
in the assays with heterotypic serotypes of FMDV. Equally impres-
sive assay speciﬁcity was demonstrated when the primer/probe
sets were used in a multiplex assay format (Table 3, supplementary
data—Annex B and Fig. 1). Five serotype Asia-1 viruses belonging
to the Sindh-08 lineage were not detected with the multiplex for-
mat. Sequencing of two of these isolates showed that this was due
to the positioning of two mismatches in the probe-binding region
(Table 4). Using either assay format, the speciﬁc primer/probe
sets were also able to identify the serotype of samples designated
FMDV-GD, thereby providing important additional epidemiological
information for these samples in the absence of any serotyping data
provided by the combined use of Ag-ELISA and VI.
The analytical sensitivity of the speciﬁc primer/probe sets as
determined by testing serial dilutions of RNA and plasmid stan-
dards demonstrated the wide dynamic range of the assays. As
with any other RNA virus with a rapidly evolving genome, con-
tinuous monitoring of the primer and probe sequences of the
serotype-speciﬁc sets against the corresponding sequences of
newly circulating and emerging viruses will be essential to ensure
that the assays maintain ﬁtness for purpose. However, the results
from this study clearly demonstrate the potential of rRT-PCR for
routine and robust detection and discrimination of FMDV isolates
belonging to geographically distinct lineages and sub-groups of
serotypes O, A and Asia-1 currently circulating in the Middle East.
Previously, a lineage-speciﬁc rRT-PCR has been developed for
use in North African countries to speciﬁcally detect SAT 2 viruses
that emerged from sub-Saharan Africa during 2012 and to differ-
entiate these viruses from endemic FMD  virus strains that might
be present in these countries (Ahmed et al., 2012). These ﬁndings
support the use of this approach to develop assays to detect other
topotypes of FMDV serotypes O, A and Asia-1, and also for other
serotypes, especially SAT 2 as viruses of this serotype have more
sequence variation in the VP1 coding sequence compared with
viruses of serotypes O, A and C. This current study is the ﬁrst to
describe the use of multiple lineage-speciﬁc rRT-PCRs for the detec-
tion and discrimination of FMDV in clinical samples in endemic
settings. These assays represent the ﬁrst step towards the develop-
ment of a suite of molecular tools (molecular toolbox) for different
countries and regions. A similar approach could therefore be used
to develop FMDV-serotyping assays for other geographical regions
of the world.
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